Normal 0 false false false EN-US X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin-top:0in; mso-para-margin-right:0in; mso-para-margin-bottom:10.0pt; mso-para-margin-left:0in; line-height:115%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin;}
The 5 Best Software to Buy for Managing a Spa Franchise
Choosing the right software translates directly into better client management, operational efficiency and growth for your spa franchise. Discover which tool is best for your business.
A fast-growing startup that makes touch-based electronic medical record applications for specialties will launch its software in two new markets next year with the $12 million it’s just raised from investors.
Modernizing Medicine‘s Series B was led by Pentland Group plc and joined by several customers-turned-investors.
The company’s Electronic Medical Assistant comes with built-in medical knowledge, adapts to each healthcare provider’s use and automates processes like billing, prescriptions, lab requests and patient handouts. After establishing itself in the dermatology, ophthalmology and optometry markets after its 2009 launch, Modernizing Medicine expanded into plastic surgery this fall.
“I was overwhelmed by the support that we received and look forward to making sure EMA remains the best EMR available on the market today,” said co-founder and CEO Dan Cane.
Understanding EGPA: The Role of Eosinophils and Advancements in Treatment Options
FASENRA® (benralizumab) injection, for subcutaneous use, 30 mg is indicated for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA). FASENRA provides a treatment option for HCPs to consider when managing this challenging disease.
With the funding, the company says it plans accelerate growth in existing markets, launch into the orthopedics and ENT markets next year and continue ongoing product innovation.
When it launches in orthopedics and ENT, Modernizing Medicine will join companies like AllMeds, OmniMD, Exscribe, NexTech and MDSMedical. Adoption of EMRs in specialty practices, however, has lagged behind other categories of physicians.
The Boca Raton, Florida, company received $3 million in seed funding from its own customers and raised an undisclosed series A in 2011.
[Photo from Modernizing Medicine]
Normal 0 false false false EN-US X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin-top:0in; mso-para-margin-right:0in; mso-para-margin-bottom:10.0pt; mso-para-margin-left:0in; line-height:115%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin;}